Chip Wilson, the visionary entrepreneur who fundamentally reshaped the world of athletic apparel with Lululemon, is now ...

Novartis has added to its pipeline of radiopharmaceuticals once again, licensing a series of agents from iTheranostics that can be used to show where tumours are located in the body. The ...

Further evidence of big pharma’s return to M&A dealmaking in 2023 has come this morning from Novartis, which has just agreed a takeover of rival Chinook Therapeutics for $3.2 billion upfront.